A phase 3 study of DTX-024 (aqubotulinumtoxinA with intradermal microinjector)
Latest Information Update: 04 May 2023
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hyperhidrosis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 04 May 2023 New trial record